CompassNow live for financial advisors
Enveda Biosciences stock

Enveda Biosciences Stock

HealthTech

Looking to sell Enveda Biosciences stock or options?

Founded: 2019Funding to Date: $829.8Mhttps://www.enveda.com

Enveda Biosciences has developed a drug analysis platform that leverages the chemical diversity and evolutionary importance of natural samples. By integrating machine learning, metabolomics, and robotics, the company's platform efficiently analyzes natural samples to determine both chemical structures and biological activities. This approach allows healthcare industry clients to identify and characterize a vast array of molecules produced by living organisms without the need for isolating individual compounds or conducting extensive experiments.

Notable investors include:
Lux Capital logo
Other investors include:

Bioverge Ventures, Martin Brenner, Baillie Gifford, Socium Ventures, Dimension (United States), FPV Ventures, True Ventures, JAZZ Venture Partners, Level Ventures, Premji Invest (US).

Own Enveda Biosciences stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure